Longikaurin E is a therapeutic agents for pancreatic cancer extracted from Isodon adenolomus. References: Cheng HB, Bo Y, Shen WX, Ren XG, Tan JN, Jia ZR, Xu CL. Longikaurin E induces apoptosis of pancreatic cancer cells via modulation of the p38 and PI3K/AKT pathways by ROS. Naunyn Schmiedebergs Arch Pharmacol. 2015 Jun;388(6):623-34. doi: 10.1007/s00210-015-1107-4. Epub 2015 Mar 6. PubMed PMID: 25743573.

纯度：≥98%

CAS：77949-42-9